Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

EMILY CAPOCCIA

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1679057715
CMS profile
11091585
Location
ROSLYN HEIGHTS, NY

General Payments · PY2021–2022

$1,005.78

  • Reported across 55 records
  • CMS publication 2026-01-23

Latest program year · PY2022

$316.49

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2022 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $316.49 17

By paying entity

PY2022 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $107.80 6
Currax Pharmaceuticals LLC $78.60 5
Ethicon US, LLC $74.44 2
Endo Pharmaceuticals Inc. $43.57 3
Teleflex LLC $12.08 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $689.29 38
PY2022 $316.49 17

Payment records · PY2022 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2022 2021 Record-level detail is published for PY2022; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Currax Pharmaceuticals LLC $16.90 02/16/2022 Food and Beverage Undisputed 01/23/2026 925778791 CMS
Currax Pharmaceuticals LLC $12.56 02/22/2022 Food and Beverage Undisputed 01/23/2026 925778793 CMS
Currax Pharmaceuticals LLC $15.28 04/15/2022 Food and Beverage Undisputed 01/23/2026 925778795 CMS
Currax Pharmaceuticals LLC $16.73 05/18/2022 Food and Beverage Undisputed 01/23/2026 925778797 CMS
Currax Pharmaceuticals LLC $17.13 08/26/2022 Food and Beverage Undisputed 01/23/2026 925778799 CMS
Endo Pharmaceuticals Inc. $14.37 02/01/2022 Food and Beverage Undisputed 01/23/2026 929722083 CMS
Endo Pharmaceuticals Inc. $17.00 03/22/2022 Food and Beverage Undisputed 01/23/2026 929722085 CMS
Endo Pharmaceuticals Inc. $12.20 06/14/2022 Food and Beverage Undisputed 01/23/2026 929722087 CMS
Ethicon US, LLC $30.36 05/09/2022 Food and Beverage Undisputed 01/23/2026 887100613 CMS
Ethicon US, LLC $44.08 08/02/2022 Food and Beverage Undisputed 01/23/2026 887100609 CMS
Novo Nordisk Inc $20.71 02/08/2022 Food and Beverage Undisputed 01/23/2026 899510143 CMS
Novo Nordisk Inc $21.66 03/04/2022 Food and Beverage Undisputed 01/23/2026 898892105 CMS
Novo Nordisk Inc $13.08 03/28/2022 Food and Beverage Undisputed 01/23/2026 899340109 CMS
Novo Nordisk Inc $18.90 04/13/2022 Food and Beverage Undisputed 01/23/2026 898612655 CMS
Novo Nordisk Inc $16.99 04/15/2022 Food and Beverage Undisputed 01/23/2026 899339991 CMS
Novo Nordisk Inc $16.46 07/12/2022 Food and Beverage Undisputed 01/23/2026 899299599 CMS
Teleflex LLC $12.08 05/24/2022 Food and Beverage Undisputed 01/23/2026 929174613 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022
Source files
Dataset page · Bulk file · PY2021 , PY2022
Generated from
OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.